Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: Candidates for T-cell- based immunotherapies?

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4090-4095

  Neumann, Elena ^a   Engelsberg, Arne ^a   Decker, Jochen ^a   Störkel, Stephan ^b   Jaeger, Elke ^c   Huber, Christoph ^a   Seliger, Barbara ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Klinikum Wuppertal   (Germany)

^c KRANKENHAUS NORDWEST   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MESSENGER RNA; TUMOR ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032530884     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Boon, T., and Van der Bruggen, P. Human tumor antigen recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
2. Rosenherg, S. A., Kawakami, Y., Robbins, P. F., and Wang, R-F. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv. Cancer Res., 70: 145-177, 1996.
3. Robbins, P. F., and Kawakami, Y. Human tumor antigen recognized by T cells. Curr. Opin. Immunol., 8: 628-636, 1997.
4. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
5. Wölfel, C., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K-H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-764, 1994.
6. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yanelli, J. B., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 179: 347-352, 1994.
7. Wang, R. F., Robbins. P. F., Kawakami, Y., Kang, X-Q., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799-804, 1995.
8. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X-Q., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 associated with in vivo tumor regression. J. Immunol., 154: 3961-3968, 1995.
9. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J-P., De Smet, C., Brasseur, F., Van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
10. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
11. Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
12. Boel, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T., and Van der Bruggen, P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
13. Van den Eynde, B., Peelers, O., De Backer, O., Baugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
14. Chen, Y. T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and Old, L. J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA, 94: 1914-1918, 1997.
15. Robbins, P. F., El-Gamil, M., Yong, F. L., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
16. Coulie, P. G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA, 92: 7976-7980, 1995.
17. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
18. Marchand, M., Weynandts, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., and Humblet, Y. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
19. Jaeger, E., Bernhard, H., Romero, P., Ringhoffer, M., Arand, M., Karbach, J., Ilsemann, C., Hagedorn, M., and Knuth, A. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer, 66: 162-169, 1996.
20. Jaeger, E., Ringhoffer, M., Dienes, H. P., Arand, M., Karbach, J., Jäger, D., Ilsemann, C., Hagedorn, M., Oesch, F., and Knuth, A. Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer, 67: 54-62, 1996.
21. Thoenes, W., Störkel, S., and Rumpelt, H. J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas): the basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract., 181: 125-143, 1986.
22. Störkel, S. F., and van den Berg, E. Morphological classification of renal cancer. World J. Urol., 13: 153-158, 1995.
23. Figlin, R. A., Abi-Aad, A. S., Belldegrun, A., and deKernion, J. B. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma. Semin. Oncol., 18 (Suppl. 7): 102-107, 1991.
24. Marincola, F. M., White, D. E., Wise, A. P., and Rosenberg, S. A. Combination therapy with interferon α-2a and interleukin-2 for the treatment of metastatic cancer. J. Clin. Oncol., 13: 1110-1122, 1995.
25. Topalian, S. L., Kasid, A., and Rosenberg, S. A. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes: possible mechanisms for immunotherapeutic failures. J. Immunol., 144: 4487-4495, 1990.
26. Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yanelli, J., and Mixon, A. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153: 1225-1237, 1994.
27. Rivoltini, L., Barracchini, D. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A., Restifo, N. P., Topalian, S. L., Simonis, T. B., and Rosenberg, S. A. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen specific cytotoxic T lymphocytes. Cancer Res., 55: 3149-3157, 1995.
28. Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Parmiani, G., Storkus, W. J., and Lotze, M. T. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with down-regulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Investig., 98: 1633-1641, 1996.
29. Rimoldi, D., Romero, P., and Carrel, S. The human melanoma antigen-encoding gene, MAGE, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer, 54: 527-528, 1993.
30. Chen, C-T., Stockert, E., Tsang, S., Coplan, K. A., and Old, L. J. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. Natl. Acad. Sci. USA, 92: 8125-8129, 1995.
31. Seliger, B., Höhne, A., Knuth, A., Bernhard, H., Meyer, T., Tampé, R., Momburg, F., and Huber, C. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res., 56: 1756-1760, 1996.
32. Wölfel. T., Hauer, M., Klehmann, E., Brichard, V., Ackermann, B., Knuth, A., Boon, T., and Meyer zum Büschenfelde, K-H. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer, 55: 237-244, 1993.
33. Brouwenstijn, N., Gaugler, B., Kruse, K. M., Van der Spek, C. W., Mulder, A., Osanto, S., Van den Eynde, B. J., and Schrier, P. I. Renal cell carcinoma-specific lysis by cylotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int. J. Cancer, 68: 177-182, 1996.
34. Seliger, B., Papadileris, S., Vogel, D., Hess, G., Brandet, C., Störkel, S., Ortel, J., Kolbe, K., Huber, C., Huhn, D., and Neubauer. A. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur. J. Hematol., 57: 230-240, 1996.
35. DeSmet, C., Lurquin, C., Van der Bruggen, P., De Plaen, E., Brasseur, F., and Boon, T. Sequence pattern of expression of human gene MACE-2. Immunogenetics, 39: 121-129, 1994.
36. Gaugler, B., Brouwenstijn, N., Vantomme, V., Szikora, J. P., Van der Spek, C. W., Patard, J. J., Boon, T., Schrier, P., and Van den Eynde, B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal cell carcinoma. Immunogenetics, 44: 323-330, 1996.
37. Knuth, A., Wolfel, T., Klehmann, T., Boon, T., and Meyer zum Büschenfelde, K-H. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA, 86: 2804-2808, 1989.
38. Ikeda, H., Lethe, B., Lehmann, F., Van Baren, N., Baurain, J. F., de Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., and Coulie, P. G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6: 199-208, 1997.
39. Kwon, B. S., Haq, A. K., Pomerantz, S. H., and Halaban, R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc. Natl. Acad. Sci. USA. 84: 7473-7477, 1987.
40. Vijayasadhi, S., Bouchard, B., and Houghton, A. N. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J. Exp. Med., 171: 1375-1380, 1990.
41. Patard, J-J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., Francois, P., Abi Aad, A., Van Cangh, P., Abbou, C. C., Chopin, D., and Boon, T. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64: 60-64, 1995.
42. Shichijo, S., Tsunossue, R., Masuoka, K., Natori, H., Tamai, M., Miyajima, J., Sagawa, K., and Itoh, K. Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol. Immunother., 41: 90-103, 1995.
43. Li, J., Yang, Y., Fujie, T., Baba, K., Ueo, H., Mori, M., and Akiyoshi, T. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin. Cancer Res., 2: 1619-1625, 1996.
44. Rosso, V., Traversari, C., Verrecchia, A., Mottolese, M., Natali, P., and Bordignon, C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for antigen-specific immunotherapy. Int. J. Cancer, 64: 216-221, 1995.
45. De Vries, T. J., Fourkour, A., Wobbes, T., Verkroost, G., Ruiter, D. J., and van Mujjen, G. N. P. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res., 57: 3223-3229, 1997.
46. Chi, D. D., Merchant, R. E., Rand, R., Conrad, A. J., Garrison, D., Turner, R., Morion, D. L., and Hoon, D. S. Molecular detection of a tumor-associated antigen shared by human cutaneous melanomas and gliomas. Am. J. Pathol., 150: 2143-2152, 1997.
47. Labarriere, N., Diez, E., Pandolfino, M-C., Viret, C., Guilloux, Y., Le Guiner, S., Fonteneau, J-F., Dreno, B., and Jotereau, F. Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. J. Immunol., 158: 1238-1245, 1997.
48. Bluestone, J. New perspectives of CD28-B7-mediated T-cell costimulation. Immunity, 2: 555-557, 1995.